Home > Services > Marketaccess reimbursement

Market Access & Reimbursement

Securing early access and reimbursement for your products

Veristat Market Access team members provide strategic advice on national early access programs, write HTA/reimbursement dossiers for submission to national HTA bodies and prepare documentation for liaison with private healthcare insurance.

Furthermore, our team supports clients with joint EMA/HTA scientific advice meetings to optimize development plans for successful regulatory and reimbursement approvals.

It's never to early to start. Let's Talk.

Market Access Roadmap

- P&R Strategy
- Routes to Market Access
- Early Access Reimbursement
- Value-based contract solution

drug and biologic market access roadmap

Health Technology Assessment (HTA)

- Dossier strategy
- Value dossier
- National HTA dossiers
- Price review

health technology assessment for market access and reimbursement

Pricing

- Competitor Analysis
- Pricing Analyses & Strategy
- Negotiation
- Price Optimization tactics

people_working_handsoverpapers

Payor Authority Management

- Payor and HCP Research
- Objection Handling
- Advisory Boards
- KOL liaison

people_working_image11

Home > Services > Marketaccess reimbursement

Ready to develop your reimbursement strategy?

Learn More with These Resources

Podcast

Scope of Things Podcast: Daphne Smyth on the Chinese Drug ...

Blog

Measuring what cant be seen how ptsd clinical trials prove a ...

Webinar Video Replay

Days Instead of Weeks: What It Actually Takes to Close the ...